Related Experiment Video
Updated: Apr 20, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Treatment of leprosy
Hemanta Kumar Kar1, Ruchi Gupta1
1Department of Dermatology, STD, and Leprosy, PGIMER & Dr RML Hospital, New Delhi, 110001, India.
Leprosy is a curable disease, with effective treatments available. However, drug resistance necessitates exploring new therapies against Mycobacterium leprae.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Leprosy, a curable infectious disease, has seen significant global reduction, notably in India.
- Effective and safe drug availability has been crucial for leprosy control and elimination efforts.
- Treatment evolved from early remedies to dapsone monotherapy and later multidrug therapy (MDT).
Purpose of the Study:
- To review the historical evolution of leprosy treatment.
- To highlight the emergence of drug resistance in Mycobacterium leprae.
- To emphasize the need for novel therapeutic strategies and clinical trials.
Main Methods:
- Historical review of leprosy treatment modalities.
- Literature analysis of drug resistance patterns.
- Identification of current therapeutic challenges.
Main Results:
- Leprosy treatment has advanced significantly over the past century.
- Increasing reports of resistance to established first-line anti-leprosy drugs are documented.
- Existing treatment regimens face challenges due to evolving drug resistance.
Conclusions:
- While leprosy is curable, drug resistance poses a growing threat to elimination efforts.
- Clinical trials investigating new, highly bactericidal drugs and combinations are essential.
- Continued research and development are vital to overcome Mycobacterium leprae resistance and ensure effective leprosy treatment.
More Related Videos
09:39DNA Fingerprinting of Mycobacterium leprae Strains Using Variable Number Tandem Repeat VNTR - Fragment Length Analysis FLA
Published on: July 15, 2011
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Psychosis: Goals of Pharmacotherapy
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Drug Therapy
Antianxiety Medications
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy